ArticleAmerican journal of cancer research2024

Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis.

Wen-Kuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.